Renal outcome , i.e. independency of renal replacement therapy 28 days after initiation of CVVH in surviving patients , did not differ between groups : 29/43 ( 67 % ) in the citrate-treated patients versus 33/47 ( 70 % ) in heparin-treated patients ( P = 0.82 ) .